We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App





High-Dose of Inexpensive and Globally Available Blood Thinner Reduces Risk of Death for Moderately Ill COVID-19 Patients

By HospiMedica International staff writers
Posted on 18 Oct 2021
Print article
Illustration
Illustration

A high dose of an inexpensive and globally available blood-thinning medication reduces the risk of death in hospitalized patients who are moderately ill with COVID-19, suggests a new study.

The international RAPID Trial led by St. Michael’s Hospital (Toronto, Canada) compared the effects of a high, therapeutic dose of heparin to a prophylactic low dose for patients with moderate COVID-19 and increased d-dimer levels admitted to hospitals. Heparin is a universally used blood thinner that prevents the formation of blood clots. D-dimers are protein fragments produced when a blood clot gets dissolved in the blood stream - increased d-dimer levels indicate higher risks of blood clots.

The researchers studied 465 patients in hospitals around the world and found that while the therapeutic dose of heparin was not associated with a significant reduction in the study’s primary outcome, a composite of death, the need for mechanical ventilation or admission to intensive care, the dosing of heparin did reduce all-cause death in moderately-ill COVID-19 patients admitted to hospital by 78%.

Therapeutic doses of heparin are used for deep vein thrombosis or pulmonary emboli, whereas prophylactic, or lower, doses are used for patients admitted to Internal Medicine wards to prevent blood clotting while they are in hospital. Several trials have explored the use of blood thinners in COVID-19 patients because the virus causes heightened inflammation and clotting in blood vessels, which contributes to severe disease and death. The researchers hope that this research contributes to a change in treatment guidelines for COVID-19 patients and could make a difference in areas where vaccine availability or coverage continues to be limited.

“Our study confirms therapeutic heparin is beneficial in patients who are on the ward with COVID-19, but other studies suggest it could be harmful for patients who are in critical care,” said Dr. Peter Jüni, Director of the Applied Health Research Centre at St. Michael’s and co-lead of the study.

“This is a once-in-a-million opportunity - heparin is inexpensive, globally available, and exists in every single hospital pharmacy cabinet right now,” added Dr. Michelle Sholzberg, Head of the Division of Hematology-Oncology and Director of the Coagulation Lab at St. Michael’s, and co-lead on the study. “It’s an opportunity to rapidly repurpose a drug available around the world.”

Related Links:
St. Michael’s Hospital

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
Diagnostic Ultrasound System
MS1700C
New
Plasma Freezer
iBF125-GX

Print article

Channels

Surgical Techniques

view channel
Image: The surgical team and the Edge Multi-Port Endoscopic Surgical Robot MP1000 surgical system (Photo courtesy of Wei Zhang)

Endoscopic Surgical System Enables Remote Robot-Assisted Laparoscopic Hysterectomy

Telemedicine enables patients in remote areas to access consultations and treatments, overcoming challenges related to the uneven distribution and availability of medical resources. However, the execution... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.